Patient, Health Care Groups Urge Congress To Ensure FDA Oversight Of LDTs

Forty-two groups, including Friends of Cancer Research, American Association for Cancer Research, American Heart Association, American Cancer Society Cancer Action Network and American Society of Clinical Oncology, are urging Congress to recognize a role for FDA in any legislation laying out a regulatory framework for laboratory developed tests (LDTs). The groups are the latest to weigh in as House lawmakers look at creating a new FDA center to regulate LDTs and Senate lawmakers instead eye reforming CMS' oversight of such...